NL7107643A - - Google Patents

Info

Publication number
NL7107643A
NL7107643A NL7107643A NL7107643A NL7107643A NL 7107643 A NL7107643 A NL 7107643A NL 7107643 A NL7107643 A NL 7107643A NL 7107643 A NL7107643 A NL 7107643A NL 7107643 A NL7107643 A NL 7107643A
Authority
NL
Netherlands
Application number
NL7107643A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7107643A publication Critical patent/NL7107643A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
NL7107643A 1970-06-10 1971-06-03 NL7107643A (cg-RX-API-DMAC7.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4524470A 1970-06-10 1970-06-10

Publications (1)

Publication Number Publication Date
NL7107643A true NL7107643A (cg-RX-API-DMAC7.html) 1971-12-14

Family

ID=21936793

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7107643A NL7107643A (cg-RX-API-DMAC7.html) 1970-06-10 1971-06-03

Country Status (8)

Country Link
US (1) US3632778A (cg-RX-API-DMAC7.html)
BE (1) BE768269A (cg-RX-API-DMAC7.html)
DE (1) DE2128461A1 (cg-RX-API-DMAC7.html)
DK (1) DK126236B (cg-RX-API-DMAC7.html)
ES (1) ES392066A1 (cg-RX-API-DMAC7.html)
FR (1) FR2100742B1 (cg-RX-API-DMAC7.html)
GB (1) GB1296505A (cg-RX-API-DMAC7.html)
NL (1) NL7107643A (cg-RX-API-DMAC7.html)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2246013A1 (de) * 1972-09-20 1974-03-28 Boehringer Mannheim Gmbh Verfahren zur herstellung von poroesen tabletten
US4017636A (en) * 1973-10-23 1977-04-12 Abbott Laboratories Esters of γ-glutamyl amide of dopamine
US4209513A (en) * 1974-02-14 1980-06-24 Burroughs Wellcome Co. Tablet formulation
DE2513940A1 (de) * 1975-03-29 1976-10-14 Merck Patent Gmbh Pharmazeutische zubereitung
US4097606A (en) * 1975-10-08 1978-06-27 Bristol-Myers Company APAP Tablet containing an alkali metal carboxymethylated starch and processes for manufacturing same
US4143129A (en) * 1975-10-11 1979-03-06 Lilly Industries Limited Cephalexin tablets
DE2551446B2 (de) * 1975-11-15 1977-09-15 Karl Werner Schlüter GmbH, 2000 Ham burg Verfahren zur herstellung von suppositorien
JPS5332111A (en) * 1976-09-07 1978-03-27 Asahi Chem Ind Co Ltd Composition for tablet
DE2845326C2 (de) * 1978-10-18 1985-05-23 Beiersdorf Ag, 2000 Hamburg Verwendung einer spezifischen mikrodispersen, amorphen, porösen Kieselsäure zur Herstellung von Digoxin enthaltenden Tabletten mit stark beschleunigter Wirkstoff-Freisetzung
US4195078A (en) * 1979-03-09 1980-03-25 Eli Lilly And Company Nabilone granulation
US4264573A (en) * 1979-05-21 1981-04-28 Rowell Laboratories, Inc. Pharmaceutical formulation for slow release via controlled surface erosion
US4547358A (en) * 1980-05-06 1985-10-15 Mead Johnson & Company Sustained release tablet containing at least 95 percent theophylline
US4465660A (en) * 1981-04-01 1984-08-14 Mead Johnson & Company Sustained release tablet containing at least 95 percent theophylline
US4327080A (en) * 1981-07-13 1982-04-27 E. R. Squibb & Sons, Inc. Novel Bendroflumethiazide formulations and method
JPS5839618A (ja) * 1981-09-04 1983-03-08 Chugai Pharmaceut Co Ltd 持続性積層錠剤
CH652025A5 (de) * 1981-09-14 1985-10-31 Hoffmann La Roche Pharmazeutisches praeparat.
US4736527A (en) * 1982-12-13 1988-04-12 Konishiroku Photo Industry Co., Ltd. Apparatus for the heat treatment of powdery material
DE3767998D1 (de) * 1986-12-20 1991-03-14 Boehringer Mannheim Gmbh Clodronat-haltige arzneimittel und verfahren zur herstellung derselben.
HU209564B (en) * 1991-01-30 1994-07-28 Egyt Gyogyszervegyeszeti Gyar Process for producing rapide tablets containing levodopa and carbidopa
TWI721946B (zh) * 2014-05-29 2021-03-21 瑞士商諾華公司 色瑞替尼調配物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3133863A (en) * 1961-03-10 1964-05-19 Strong Cobb Arner Inc Sustained release therapeutic tablet compositions comprising organic solvent-gelled gums
US3458622A (en) * 1967-04-07 1969-07-29 Squibb & Sons Inc Controlled release tablet
US3557292A (en) * 1968-08-16 1971-01-19 Hoffmann La Roche Compositions and methods for treating parkinson's disease with combinations of l-3,4-dihydroxyphenylalanine and a hydrazine

Also Published As

Publication number Publication date
FR2100742A1 (cg-RX-API-DMAC7.html) 1972-03-24
US3632778A (en) 1972-01-04
DE2128461A1 (de) 1971-12-16
BE768269A (fr) 1971-12-09
GB1296505A (cg-RX-API-DMAC7.html) 1972-11-15
ES392066A1 (es) 1974-10-16
DK126236B (da) 1973-06-25
FR2100742B1 (cg-RX-API-DMAC7.html) 1974-09-06

Similar Documents

Publication Publication Date Title
DE2127162B2 (cg-RX-API-DMAC7.html)
DK509674A (cg-RX-API-DMAC7.html)
FR2100742B1 (cg-RX-API-DMAC7.html)
JPS475417A (cg-RX-API-DMAC7.html)
CS174167B2 (cg-RX-API-DMAC7.html)
JPS4812496B1 (cg-RX-API-DMAC7.html)
FR2075097A5 (cg-RX-API-DMAC7.html)
CS171693B2 (cg-RX-API-DMAC7.html)
HU162519B (cg-RX-API-DMAC7.html)
FR2089905A5 (cg-RX-API-DMAC7.html)
JPS4820844B1 (cg-RX-API-DMAC7.html)
JPS4820844Y1 (cg-RX-API-DMAC7.html)
FR2022077A1 (cg-RX-API-DMAC7.html)
HU162806B (cg-RX-API-DMAC7.html)
DE2048098A1 (cg-RX-API-DMAC7.html)
DE2120530C3 (cg-RX-API-DMAC7.html)
FR2045322A7 (cg-RX-API-DMAC7.html)
FR2074846A5 (cg-RX-API-DMAC7.html)
FR2069327A5 (cg-RX-API-DMAC7.html)
JPS4819598B1 (cg-RX-API-DMAC7.html)
JPS505304Y1 (cg-RX-API-DMAC7.html)
JPS486741Y1 (cg-RX-API-DMAC7.html)
JPS4841834B1 (cg-RX-API-DMAC7.html)
JPS481841Y1 (cg-RX-API-DMAC7.html)
JPS4738741Y1 (cg-RX-API-DMAC7.html)